We are committed to improving the care of patients with immune-regulated conditions by providing funding or other forms of support to qualified investigators who share our commitment and work within our areas of interest. All physicians, healthcare providers, researchers and institutions around the world who conduct their own research and share the same commitment are invited to submit a study proposal under the areas of interest including but not exclusive of:
Tuberculosis (TB)
- Studies to optimize further use of the T-SPOT™.TB test as a means of diagnosis; for example (but not limited to), as a means of detecting disease progression, or for differentiating active versus latent TB infection, or for identifying other potential non-tuberculous mycobacteria infections.
- TB testing in rheumatology, cancer, ulcerative colitis or Crohn’s disease patients receiving biologics
COVID-19
- General prospective studies in the elderly, paediatrics and patients with comorbidities and immunosuppressed
Cytomegalovirus (CMV)
- Interventional studies
- Congenital CMV
- Transplant
Other
- Prospective studies to explore performance of T-SPOT technology-based tests in immunosuppressed group
All proposals are reviewed by a select review committee against criteria which includes scientific merit and alignment with the Company’s areas of interest. The investigator and/or institution responsibilities include study design, execution and compliance with all local and international regulatory requirements. Support is subject to availability of resource and conditioned upon an approved study concept proposal, full study protocol and full execution of a research support agreement by both parties.
For more information, please click here to download the Investigator Led Study Proposal form. Please submit both the cover letter and study protocol to us at researchstudies_idx@revvity.com.
Eligibility criteria
The proposed study should be:
- For a legitimate research purpose, and it must have scientific merit in a research area which complements the companies research
The Investigator applying for an Investigator Led Study must meet the following criteria:
- Have the appropriate infrastructure and resource in place to conduct the proposed study, e.g., the site has the scientific, technical, statistical and operational capabilities to conduct a study as a sponsor (including trained staff to execute the study)
- Have already obtained IRB/Ethics approval, or be willing to obtain approval within 1 month of submission to Revvity
- Have recent clinical research experience within the previous 3 years, evidenced by publications, congress presentations etc.
- Have obtained Good Clinical Practice (GCP) training within the previous 3 years
- Deliver to agreed timelines
- Be able to meet all regulatory requirements, including writing of a final study report and manuscripts
- Be able to publish the study in a peer-reviewed scientific journal
Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.